Michael Foote was at dinner with three friends at Soothr, a Thai restaurant in the East Village of Manhattan, when he looked ...

New data suggests the weight-loss drug Wegovy may significantly reduce the risk of heart disease even before users experience ...

The company found some relief after adding GLP-1 obesity treatment offerings in 2023, but still hasn’t strayed from the more traditional approach to weight loss, focusing on food intake and ...

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

GLP-1s may help reduce alcohol intake among adults with overweight or obesity, according to data presented at the European ...

Though popular weight loss jabs like Ozempic and Wegovy have been deemed safe and effective by the FDA, concerning side ...

Popular obesity and diabetes drugs called GLP-1 medications may have added benefits, with a new study finding they helped heavy drinkers cut alcohol consumption by nearly 70%.

Medications like semaglutide and liraglutide may help to reduce the risk for heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with obesity and ...

The company’s blockbuster drugs helped it beat Wall Street’s expectations—while WeightWatchers declares bankruptcy. One day ...

Metamorphx is emerging as a leading natural GLP-1 alternative for weight loss in 2025. With prescription options like ...